Two previous studies, one in neuroblastoma cells [20] and another in a mouse derived Eμ-myc driven lymphoma cell model [25], identified increased oncogenic replicative stress due to amplification of the Myc oncogene as a potential underlying mechanism for sensitivity to Chk1 inhibition. The gene discussed is MYC; the disease is lymphoma.